Dean Moss BSc, MPhil, PhD (UQ), GAICD

Chief Executive Officer 

Dr Dean Moss is CEO of UniQuest, Australia’s leading university commercialisation entity, managing the intellectual property of The University of Queensland.

Dr Moss has more than 30 years’ experience in science, academia, business, management and commercialisation in Australia, the US and the UK.

He has been managing director or senior business development executive of several health and biotech companies worldwide, including Agen Biomedical, Launch Diagnostics, AMRAD ICT, AMRAD Biotech, and United Drug. Dr Moss established the highly-successful York Medical Technologies as a start-up in the UK in 2004.

He is a board member of several Australian biotechnology companies and was a member of the investment committee of the pre-seed venture funds Uniseed, the Medical Research Commercialisation Fund and the New Zealand Government’s KiwiNet.

Throughout his career, Dr Moss has managed the raising of more than $100M in venture capital investment.

He sits on the NHMRC Health Innovation Advisory Committee and is Chair of the Go8 Innovation and Commercialisation Group. In 2018, Dr Moss was awarded the title of Adjunct Professor in the Office of the UQ’s Deputy Vice-Chancellor (Research).

Mark Ashton BSc (Hons), PhD

Executive Director, Intellectual Property Commercialisation

Dr Mark Ashton joined UniQuest in 2010 and is currently the Executive Director of Intellectual Property Commercialisation.  Prior to this he was the Manager of Innovation and Commercial Development for The Institute for Molecular Bioscience and Health Sciences at The University of Queensland. Before joining UniQuest Dr Ashton was the Executive Vice President, Business Development at the international biotech, Evotec AG, a company that focuses on drug discovery alliances and development partnerships with the pharmaceutical and biotech industry.  Prior to leading the business development group at Evotec, Dr Ashton was President, Discovery Services at Evotec, responsible for the company’s Drug Discovery division, a division that carried out projects involving high throughput screening, parallel synthesis and medicinal chemistry to pre-clinical development. Dr Ashton has worked within the biotech and pharmaceutical industry since the early 1990’s and has both operational and commercial experience of a wide range of life science projects. He has worked with most of the major pharmaceutical companies and a number of biotech companies around the world negotiating agreements totalling in excess of $100M. Dr Ashton is the author and co-author of a number of peer reviewed scientific publications and patents including new chemical entities that have progressed to human clinical trials. He has a PhD in chemistry having worked on a medicinal chemistry focussed project sponsored by an international pharmaceutical company.


Jane Malloch BA LLB

General Counsel

Jane Malloch joined UniQuest in July 2017 after leading The University of Queensland (UQ) Research Legal team for more than a decade, providing expert legal advice and solutions to the UQ research community and support for university commercialisation. She has extensive experience in commercial negotiations and agreements. Prior to UQ, Ms Malloch was a University of Technology Sydney Senior University Lawyer and the Director of Legal Services at Griffith University. Before entering the higher education sector, she was a Commercial Officer for Nabalco (now Rio Tinto ALCAN Gove)  and gained broad-based legal experience with an emphasis on litigation in private law firms in Sydney and New Zealand.